Pharmacologic treatment of irritable bowel syndrome. Position statement of the Asociación Mexicana de Gastroenterología, 2024 J.M. Remes-Troche; E. Coss-Adame; M. Schmulson; K.R. García-Zermeño; M. Amieva-Balmori; R. Carmona-Sánchez; O. Gómez-Escudero; P.C. Gómez-Castaños; M.E. Icaza-Chávez; A. López-Colombo; E.C. Morel-Cerda; M.Á. Valdovinos-Díaz; L.R. Valdovinos-García; A.S. Villar-Chávez;

Prevalence of methanogens and associated factors in patients with irritable bowel syndrome and healthy controls in a Southeastern Mexican population M.G. Aja-Cadena; M. Amieva-Balmori; H.A. Taboada-Liceaga; O.J. Cobos-Quevedo; G.A. Hernández-Ramírez; J. Reyes-Huerta; F. Roesch-Dietlen; A. Meixuerio-Daza; J.M. Remes-Troche;

An App model that utilizes a logistic regression algorithm for predicting choledocholithiasis: A prospective clinical trial F. García-Villarreal; L.M. Torres-Treviño; C. Herrera-Figueroa; J.O. Jáquez-Quintana; A.A. Garza-Galindo; C.A. Cortez-Hernández; D. García-Compeán; R.A. Jiménez-Castillo; H.J. Maldonado-Garza; J.A. González-González;